Metastatic Colorectal Cancers Withdrawn Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01175291FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal CancerTreatment
NCT01293942IXO+A in mCRC With Liver-only MetastasesTreatment